Hepatitis C in pregnancy

Sangeeta Jain, Nima Goharkhay, George Saade, Gary Hankins, Garland D. Anderson

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Hepatitis C is the most common cause of chronic liver disease and liver transplantation, with 25,000 cases reported in the United States per year. By blood product screening, transfusion-related viral transmission has been virtually eliminated, and maternal fetal transmission is now one of the most important modes of transmission. Hepatitis C virus (HCV) infection is blood borne but only 25% of the infected pregnant women indicate a history of blood products transfusion or intravenous drug use. HCV transmission is 2- to 4-fold higher in women coinfected with HIV. Although cesarean delivery has not been shown to decrease perinatal transmission, it may have benefits in women with viremia at the time of delivery. During pregnancy, treatment of HCV is contraindicated, even though perinatal transmission is associated with a higher incidence of chronic liver disease. This review gives an update on the disease agent, risk factors, modes of transmission, diagnosis, treatment modalities, and perinatal issues that require further evaluation.

Original languageEnglish (US)
Pages (from-to)251-256
Number of pages6
JournalAmerican Journal of Perinatology
Volume24
Issue number4
DOIs
StatePublished - Apr 2007

Fingerprint

Hepatitis C
Hepacivirus
Pregnancy
Liver Diseases
Chronic Disease
Viremia
Virus Diseases
Blood Transfusion
Liver Transplantation
Pregnant Women
Mothers
HIV
Incidence
Therapeutics
Pharmaceutical Preparations

Keywords

  • Cesarean delivery
  • Hepatitis C virus
  • Perinatal transmission
  • Pregnancy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Jain, S., Goharkhay, N., Saade, G., Hankins, G., & Anderson, G. D. (2007). Hepatitis C in pregnancy. American Journal of Perinatology, 24(4), 251-256. https://doi.org/10.1055/s-2007-970181

Hepatitis C in pregnancy. / Jain, Sangeeta; Goharkhay, Nima; Saade, George; Hankins, Gary; Anderson, Garland D.

In: American Journal of Perinatology, Vol. 24, No. 4, 04.2007, p. 251-256.

Research output: Contribution to journalArticle

Jain, S, Goharkhay, N, Saade, G, Hankins, G & Anderson, GD 2007, 'Hepatitis C in pregnancy', American Journal of Perinatology, vol. 24, no. 4, pp. 251-256. https://doi.org/10.1055/s-2007-970181
Jain, Sangeeta ; Goharkhay, Nima ; Saade, George ; Hankins, Gary ; Anderson, Garland D. / Hepatitis C in pregnancy. In: American Journal of Perinatology. 2007 ; Vol. 24, No. 4. pp. 251-256.
@article{d982af726f2841dd8cc36acc68e818a7,
title = "Hepatitis C in pregnancy",
abstract = "Hepatitis C is the most common cause of chronic liver disease and liver transplantation, with 25,000 cases reported in the United States per year. By blood product screening, transfusion-related viral transmission has been virtually eliminated, and maternal fetal transmission is now one of the most important modes of transmission. Hepatitis C virus (HCV) infection is blood borne but only 25{\%} of the infected pregnant women indicate a history of blood products transfusion or intravenous drug use. HCV transmission is 2- to 4-fold higher in women coinfected with HIV. Although cesarean delivery has not been shown to decrease perinatal transmission, it may have benefits in women with viremia at the time of delivery. During pregnancy, treatment of HCV is contraindicated, even though perinatal transmission is associated with a higher incidence of chronic liver disease. This review gives an update on the disease agent, risk factors, modes of transmission, diagnosis, treatment modalities, and perinatal issues that require further evaluation.",
keywords = "Cesarean delivery, Hepatitis C virus, Perinatal transmission, Pregnancy",
author = "Sangeeta Jain and Nima Goharkhay and George Saade and Gary Hankins and Anderson, {Garland D.}",
year = "2007",
month = "4",
doi = "10.1055/s-2007-970181",
language = "English (US)",
volume = "24",
pages = "251--256",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers",
number = "4",

}

TY - JOUR

T1 - Hepatitis C in pregnancy

AU - Jain, Sangeeta

AU - Goharkhay, Nima

AU - Saade, George

AU - Hankins, Gary

AU - Anderson, Garland D.

PY - 2007/4

Y1 - 2007/4

N2 - Hepatitis C is the most common cause of chronic liver disease and liver transplantation, with 25,000 cases reported in the United States per year. By blood product screening, transfusion-related viral transmission has been virtually eliminated, and maternal fetal transmission is now one of the most important modes of transmission. Hepatitis C virus (HCV) infection is blood borne but only 25% of the infected pregnant women indicate a history of blood products transfusion or intravenous drug use. HCV transmission is 2- to 4-fold higher in women coinfected with HIV. Although cesarean delivery has not been shown to decrease perinatal transmission, it may have benefits in women with viremia at the time of delivery. During pregnancy, treatment of HCV is contraindicated, even though perinatal transmission is associated with a higher incidence of chronic liver disease. This review gives an update on the disease agent, risk factors, modes of transmission, diagnosis, treatment modalities, and perinatal issues that require further evaluation.

AB - Hepatitis C is the most common cause of chronic liver disease and liver transplantation, with 25,000 cases reported in the United States per year. By blood product screening, transfusion-related viral transmission has been virtually eliminated, and maternal fetal transmission is now one of the most important modes of transmission. Hepatitis C virus (HCV) infection is blood borne but only 25% of the infected pregnant women indicate a history of blood products transfusion or intravenous drug use. HCV transmission is 2- to 4-fold higher in women coinfected with HIV. Although cesarean delivery has not been shown to decrease perinatal transmission, it may have benefits in women with viremia at the time of delivery. During pregnancy, treatment of HCV is contraindicated, even though perinatal transmission is associated with a higher incidence of chronic liver disease. This review gives an update on the disease agent, risk factors, modes of transmission, diagnosis, treatment modalities, and perinatal issues that require further evaluation.

KW - Cesarean delivery

KW - Hepatitis C virus

KW - Perinatal transmission

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=34247567815&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247567815&partnerID=8YFLogxK

U2 - 10.1055/s-2007-970181

DO - 10.1055/s-2007-970181

M3 - Article

C2 - 17447189

AN - SCOPUS:34247567815

VL - 24

SP - 251

EP - 256

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

IS - 4

ER -